$26M sweet spot round size
Most of their 68 investments are in rounds between $16M and $37M
1997
Sutro Biopharma, Inc. raised $85M on July 26, 2018
Investors: Nexthera Capital, Tekla Capital Management, Samsara BioCapital, Surveyor Capital, Vida Ventures, LLC, SV Life Sciences, Lilly Ventures and Sky Ventures
Dicerna Pharmaceuticals, Inc. raised $70M on March 30, 2017
Investors: RA Capital Management, L.P., Domain Associates and Sky Ventures
SI-BONE raised $26M on June 17, 2016
Investors: Montreux Equity Partners, OrbiMed Advisors, Redline Capital and Sky Ventures
SI-BONE raised $21M on May 26, 2015
Investors: Montreux Equity Partners, Redline Capital, OrbiMed Advisors and Sky Ventures
Undisclosed raised $45M on May 16, 2014
Investors: Devon Park Bioventures, TVM Life Science Management Inc, MPM Capital, Prism Venture Partners, Inbio Ventures, Intersouth Partners and Sky Ventures
SI-BONE raised $33M on April 28, 2014
Investors: Montreux Equity Partners, Novo Holdings, OrbiMed Advisors and Sky Ventures
Sutro Biopharma, Inc. raised $26M on December 11, 2013
Investors: SV Life Sciences, Celgene, Alta Partners and Sky Ventures
Dicerna Pharmaceuticals, Inc. raised $60M on July 31, 2013
Investors: Domain Associates, Brookside Capital Inc, RA Capital Management, L.P., S.R. One Ltd, Abingworth, Omega Funds and Sky Ventures
Undisclosed raised $28M on January 3, 2013
Investors: Aeris Capital AG, Kleiner Perkins, Mohr Davidow Ventures, Safeguard Scientifics and Sky Ventures
Sutro Biopharma, Inc. raised $17M on May 8, 2012
Investors: Alta Partners, SV Life Sciences, Lilly Ventures and Sky Ventures